Characterization of bone-marrow-derived rat mesenchymal stem cells depending on donor age

Cell Biology International

Volumn 35, Issue 10, 2011, Pages 1055-1062

  Gala, Kamila ^a   Burdzińska, Anna ^a   Idziak, Marta ^a   Makula, Jolanta ^a   Paczek, Leszek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Aging; Bone marrow; Cytokine; Interleukin 1a (IL 1a); Mesenchymal stem cell (MSC)

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HYDROGEN PEROXIDE; INTERLEUKIN 1ALPHA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADIPOGENESIS; AGE DISTRIBUTION; AGING; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DONOR; GENE EXPRESSION; IN VITRO STUDY; MESENCHYMAL STEM CELL; MITOGENESIS; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PROTEIN SECRETION;

ADIPOGENESIS; AGE FACTORS; ANIMALS; BONE MARROW CELLS; CELL SURVIVAL; FIBROBLAST GROWTH FACTOR 2; HYDROGEN PEROXIDE; IMMUNOPHENOTYPING; INTERLEUKIN-1ALPHA; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RATS; RATS, INBRED LEW; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 80054972499     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100586     Document Type: Article

References (42)

1. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001;20:2254-72.
2. Burdzinska A, Bartoszuk U, Orzechowski A. Preincubation with bFGF but not sodium ascorbate improves efficiency of autologous transplantation of muscle-derived cells into urethral wall. Urology 2009;737:736-42.
3. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-5.
4. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 2001;98:7841-5.
5. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M et al. Transplantability and therapeutic effects of bone marrowderived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-13.
6. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932-7.
7. Imanishi Y, Saito A, Komoda H, Kitagawa-Sakakida S, Miyagawa S, Kondoh H et al. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol 2008;44:662-71.
8. Ishikane S, Ohnishi S, Yamahara K, Sada M, Harada K, Mishima K et al. Allogenic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 2008;26:2625-33.
9. Jiang S, Kh Haider H, Ahmed RP, Idris NM, Salim A, Ashraf M. Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. J Mol Cell Cardiol 2008;44: 582-96.
10. Jiang X, Zou S, Ye B, Zhu S, Liu Y, Hu J. bFGF-modified BMMSCs enhance bone regeneration following distraction osteogenesis in rabbits. Bone 2010;46:1156-61.
11. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 2002;71:36-44.
12. Kretlow JD, Jin YO, Liu W, Zhang WJ, Hong TH, Zhou G et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008;9:60
13. Kunter U, Rong S, Djuric Z, Boor P, Müller-Newen GD, Yu D et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006;17:2202-212.
14. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-86.
15. Lee SK, Kim Y, Kim SS, Lee JH, Cho K, Lee SS et al. Differential expression of cell surface proteins in human bone marrow mesenchymal stem cells cultured with or without basic fibroblast growth factor containing medium. Proteomics 2009;9:4389-405.
16. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signalling pathways. Aging Cell 2004;3:379-89.
17. Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival inmice, Stem Cells 2008;26:2075-82.
18. Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S, Yasunaga Y. Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng 2004;10:1093-112.
19. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114-120.
20. Niemeyer P, Vohrer J, Schmal H, Kasten P, Fellenberg J, Suedkamp NP et al. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy 2008;10:784-95.
21. Nuttall ME, Gimble JM. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 2000;27:177-84.
22. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surfacebound IL-1 alpha is an upstream regulator of the senescenceassociated IL-6/IL-8 cytokine network. Proc Natl Acad Sci USA 2009;106:17031-6.
23. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
24. Poncelet AJ, Vercruysse J, Saliez A, Gianello P. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 2007;83:783-90.
25. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-6.
26. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008;2:141-50.
27. Roura S, Farré J, Soler-Botija C, Llach A, Hove-Madsen L, Cairó JJ et al.. Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells. Eur J Heart Fail 2006;8:555-63.
28. Shabbir A, Zisa D, Leiker M, Johnston C, Lin H, Lee T. Muscular dystrophy therapy by nonautologous mesenchymal stem cells:muscle regeneration without immunosuppression and inflammation. Transplantation 2009;87:1275-82.
29. Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 2007;69:1-9.
30. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-26.
31. Stolzing A, Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell 2006;5:213-24.
32. Stolzing E, Jones D, McGonagle A, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008;129:163-73.
33. Takeda M, Shirato I, Kobayashi M, Endou H. Hydrogen peroxide induces necrosis, apoptosis, oncosis and apoptotic oncosis of mouse terminal proximal straight tubule cells. Nephron 1999;81:234-8.
34. Teramoto S, Tomita T, Matsui H, Ohga E, Matsuse T, Ouchi Y. Hydrogen peroxide-induced apoptosis and necrosis in human lung fibroblasts: protective roles of glutathione. Jpn J Pharmacol 1999;79:33-40.
35. Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007;292:1626-35.
36. Tokalov SV, Gruener S, Schindler S, Iagunov AS, Baumann M, Abolmaali ND. A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. Mol Cells 2007;24:255-60.
37. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001;288:413-19.
38. van den Bos C, Mosca JD, Winkles J, Kerrigan L, Burgess WH, Marshak DR. Human mesenchymal stem cells respond to fibroblast growth factors. Hum Cell 1997;10:45-50.
39. Wang YQ, Wang M, Zhang P, Song JJ, Li YP, Hou SH et al. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction. Chin Med J 2008;121:2290-8.
40. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008;7:335-43.
41. Zhuang S, Kinsey GR, Yan Y, Han J, Schnellmann RG. Extracellular signal-regulated kinase activation mediates mitochondrial dysfunction and necrosis induced by hydrogen peroxide in renal proximal tubular cells. J Pharmacol Exp Ther 2008;325:732-40.
42. Zisa D, Shabbir A, Suzuki G, Lee T. Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochem Biophys Res Commun 2009;390:834-8.